| Characteristic | Low expression of TM4SF19 | High expression of TM4SF19 | p |
| n | 207 | 207 | |
| T stage, n (%) |
|
| 0.003 |
| T1 | 3 (0.8%) | 2 (0.5%) |
|
| T2 | 75 (19.7%) | 44 (11.6%) |
|
| T3 | 83 (21.8%) | 113 (29.7%) |
|
| T4 | 28 (7.4%) | 32 (8.4%) |
|
| N stage, n (%) |
|
| 0.103 |
| N0 | 124 (33.5%) | 115 (31.1%) |
|
| N1 | 19 (5.1%) | 27 (7.3%) |
|
| N2 | 38 (10.3%) | 39 (10.5%) |
|
| N3 | 1 (0.3%) | 7 (1.9%) |
|
| M stage, n (%) |
|
| 0.209 |
| M0 | 119 (55.9%) | 83 (39%) |
|
| M1 | 4 (1.9%) | 7 (3.3%) |
|
| Pathologic stage, n (%) |
|
| 0.005 |
| Stage I | 3 (0.7%) | 1 (0.2%) |
|
| Stage II | 80 (19.4%) | 50 (12.1%) |
|
| Stage III | 61 (14.8%) | 81 (19.7%) |
|
| Stage IV | 61 (14.8%) | 75 (18.2%) |
|
| Radiation therapy, n (%) |
|
| 0.194 |
| No | 182 (46.9%) | 185 (47.7%) |
|
| Yes | 14 (3.6%) | 7 (1.8%) |
|
| Primary therapy outcome, n (%) |
|
| <0.001 |
| PD | 21 (5.9%) | 49 (13.7%) |
|
| SD | 13 (3.6%) | 18 (5%) |
|
| PR | 11 (3.1%) | 11 (3.1%) |
|
| CR | 133 (37.3%) | 101 (28.3%) |
|
| Gender, n (%) |
|
| 0.264 |
| Female | 49 (11.8%) | 60 (14.5%) |
|
| Male | 158 (38.2%) | 147 (35.5%) |
|
| Race, n (%) |
|
| <0.001 |
| Asian | 36 (9.1%) | 8 (2%) |
|
| Black or African American | 11 (2.8%) | 12 (3%) |
|
| White | 151 (38%) | 179 (45.1%) |
|
| Age, n (%) |
|
| 0.921 |
| ≤70 | 118 (28.5%) | 116 (28%) |
|
| >70 | 89 (21.5%) | 91 (22%) |
|
| Weight, n (%) |
|
| 0.437 |
| ≤80 | 107 (28.8%) | 98 (26.4%) |
|
| >80 | 79 (21.3%) | 87 (23.5%) |
|
| Height, n (%) |
|
| 0.351 |
| ≤170 | 85 (23.3%) | 73 (20%) |
|
| >170 | 100 (27.4%) | 107 (29.3%) |
|
| BMI, n (%) |
|
| 0.128 |
| ≤25 | 85 (23.4%) | 68 (18.7%) |
|
| >25 | 99 (27.2%) | 112 (30.8%) |
|
| Histologic grade, n (%) |
|
| <0.001 |
| High Grade | 186 (45.3%) | 204 (49.6%) |
|
| Low Grade | 19 (4.6%) | 2 (0.5%) |
|
| Subtype, n (%) |
|
| <0.001 |
| Non-Papillary | 115 (28.1%) | 160 (39.1%) |
|
| Papillary | 90 (22%) | 44 (10.8%) |
|
| Lymphovascular invasion, n (%) |
|
| 0.680 |
| No | 67 (23.7%) | 63 (22.3%) |
|
| Yes | 74 (26.1%) | 79 (27.9%) |
|
| Smoker, n (%) |
|
| 0.632 |
| No | 57 (14.2%) | 52 (13%) |
|
| Yes | 143 (35.7%) | 149 (37.2%) |
|
| OS event, n (%) |
|
| <0.001 |
| Alive | 133 (32.1%) | 98 (23.7%) |
|
| Dead | 74 (17.9%) | 109 (26.3%) |
|
| DSS event, n (%) |
|
| 0.002 |
| Alive | 152 (38%) | 122 (30.5%) |
|
| Dead | 48 (12%) | 78 (19.5%) |
|
| PFI event, n (%) |
|
| 0.007 |
| Alive | 131 (31.6%) | 103 (24.9%) |
|
| Dead | 76 (18.4%) | 104 (25.1%) |
|
| Age, median (IQR) | 68 (59, 75) | 69 (61.5, 76) | 0.223 |